Shitomi-Jones Lisa M, Dolman Clare, Jones Ian, Kirov George, Escott-Price Valentina, Legge Sophie E, Di Florio Arianna
Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Bipolar UK, London, UK.
Nat Ment Health. 2024;2(10):1161-1168. doi: 10.1038/s44220-024-00292-4. Epub 2024 Aug 15.
Although the relationship between perimenopause and changes in mood has been well established, knowledge of risk of a broad spectrum of psychiatric disorders associated with reproductive aging is limited. Here we investigate whether the perimenopause (that is, the years around the final menstrual period (FMP)) is associated with increased risk of developing psychiatric disorders compared with the late reproductive stage. Information on menopausal timing and psychiatric history was obtained from nurse-administered interviews and online questionnaires from 128,294 female participants within UK Biobank. Incidence rates of psychiatric disorders during the perimenopause (4 years surrounding the FMP) were compared with the reference premenopausal period (6-10 years before the FMP). The rates were calculated for major depressive disorder (MDD), mania, schizophrenia spectrum disorders and other diagnoses. Overall, of 128,294 participants, 753 (0.59%) reported their first onset of a psychiatric disorder during the late reproductive stage (incidence rate 1.53 per 1,000 person-years) and 1,133 (0.88%) during the perimenopause (incidence rate 2.33 per 1,000 person-years). Compared with the reference reproductive period, incidence rates of psychiatric disorders significantly increased during the perimenopause (incidence rate ratio (RR) of 1.52, 95% confidence interval (CI) 1.39-1.67) and decreased back down to that observed in the premenopausal period in the postmenopause (RR of 1.09 (95% CI 0.98-1.21)). The effect was primarily driven by increased incidence rates of MDD, with an incidence RR of 1.30 (95% CI 1.16-1.45). However, the largest effect size at perimenopause was observed for mania (RR of 2.12 (95% CI 1.30-3.52)). No association was found between perimenopause and incidence rates of schizophrenia spectrum disorders (RR of 0.95 (95% CI 0.48-1.88)). In conclusion, perimenopause was associated with an increased risk of developing MDD and mania. No association was found between perimenopause and first onsets of schizophrenia spectrum disorders.
尽管围绝经期与情绪变化之间的关系已得到充分证实,但关于与生殖衰老相关的广泛精神障碍风险的了解仍然有限。在此,我们调查围绝经期(即末次月经(FMP)前后数年)与生殖晚期相比,患精神障碍风险是否增加。绝经时间和精神病史信息来自英国生物银行中128,294名女性参与者的护士访谈和在线问卷。将围绝经期(FMP前后4年)的精神障碍发病率与绝经前参考期(FMP前6 - 10年)进行比较。计算了重度抑郁症(MDD)、躁狂症、精神分裂症谱系障碍及其他诊断的发病率。总体而言,在128,294名参与者中,753人(0.59%)报告在生殖晚期首次出现精神障碍(发病率为每1000人年1.53例),1133人(0.88%)在围绝经期首次出现(发病率为每1000人年2.33例)。与参考生殖期相比,围绝经期精神障碍发病率显著增加(发病率比(RR)为1.52,95%置信区间(CI)为1.39 - 1.67),绝经后又降至绝经前观察到的水平(RR为1.09(95% CI为0.98 - 1.21))。这种影响主要由MDD发病率增加驱动,发病率RR为1.30(95% CI为1.16 - 1.45)。然而,围绝经期躁狂症的效应量最大(RR为2.12(95% CI为1.30 - 3.52))。未发现围绝经期与精神分裂症谱系障碍发病率之间存在关联(RR为0.95(95% CI为0.48 - 1.88))。总之,围绝经期与患MDD和躁狂症的风险增加有关。未发现围绝经期与精神分裂症谱系障碍的首次发病之间存在关联。